Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suzetrigine for Postoperative Pain After Total Knee Arthroplasty
NCT07357376Phase 3Not yet recruiting
- Sponsor
- AdventHealth
- Start
- Mar 2026
- Primary completion
- Jul 2026
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of suzetrigine in postoperative pain, sponsored by AdventHealth. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
suzetrigine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07357376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07357376.